【英文論文】

Rennie D, Karunanayake CP, Chen Y, Nakagawa K, Pahwa P, Senthilselvan A, Dosman JA.
CD14 gene variants and their importance for childhood croup, atopy and asthma.
Dis Markers. 2013;35(6):765-71.

Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K.
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia.
Neuropsychiatr Dis Treat. 2013;9:1683-98.

Kajiwara A, Saruwatari J, Kita A, Kamihashi R, Miyagawa H, Sakata M, Noai M, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.
Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy: a retrospective longitudinal study in Japanese patients with type 2 diabetes.
Pharmacogenet Genomics. 2013;23(12):717-20.

Morita K, Saruwatari J, Miyagawa H, Uchiyashiki Y, Oniki K, Sakata M, Kajiwara A, Yoshida A, Jinnouchi H, Nakagawa K.
Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.
Cardiovasc Diabetol. 2013;12(1):132.

Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui K, Ogawa H.
Response to letter regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".
Circ Cardiovasc Interv. 2013; 6(5):e66.

Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui K, Ogawa H.
Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Circ Cardiovasc Interv. 2013;6(4):452-9.

Kajiwara A, Saruwatari J, Sakata M, Morita K, Kita A, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.
Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: A questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto prefecture.
Drug Saf. 2013;36(10):981-7.

Oniki K, Hori M, Saruwatari J, Morita K, Kajiwara A, Sakata M, Mihara S, Ogata Y, Nakagawa K.
Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease.
Toxicol Lett. 2013;220(2):143-9.

Sakata M, Oniki K, Kita A, Kajiwara A, Uchiyashiki Y, Saruwatari J, Yoshida A, Jinnouchi H, Nakagawa K.
Clinical features associated with a rapid decline in the renal function among Japanese patients with type 2 diabetes mellitus: Microscopic hematuria coexisting with diabetic retinopathy.
Diabetes Res Clin Pract. 2013;100(2):e39-41.

Nakagawa T, Kajiwara A, Saruwatari J, Hamamoto A, Kaku W, Oniki K, Mihara S, Ogata Y, Nakagawa K.
The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption.
Pharmacogenet Genomics. 2013;23(1):34-7.

【和文総説】

猿渡淳二、空岡裕美、髙嶋綾佳．
漢方薬と西洋薬の相互作用（チトクロムP450 に関して）．
漢方と最新治療.2013;22:287-291.